Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study

Clinical trial NCT07085182 · RECRUITING

Trial details

NCT number: NCT07085182
Sponsor: Zibo Municipal Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Tislelizumab Chemotherapy Hypofractionated Radiotherapy

Start date: 2024-01-13
Primary completion: 2027-12-10
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.